ProjectEORTC-1301-LG – 1301-LG
Basic data
Acronym:
EORTC-1301-LG
Title:
1301-LG
Duration:
01/05/2015 to 31/12/2022
Abstract / short description:
"10-day decitabine versus conventional chemotherapy (“3+7”)
followed by allografting in AML patients ≥ 60 years: a
randomized phase III study of the EORTC Leukemia Group,
CELG, GIMEMA and German MDS Study Group [AML-21]"
followed by allografting in AML patients ≥ 60 years: a
randomized phase III study of the EORTC Leukemia Group,
CELG, GIMEMA and German MDS Study Group [AML-21]"
Keywords:
AML
>= 60 Jahre
Involved staff
Managers
Department of Internal Medicine
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Cluster of Excellence: Image-Guided and Functionally Instructed Tumor Therapies (iFIT)
Centers or interfaculty scientific institutions
Centers or interfaculty scientific institutions
Contact persons
Faculty of Medicine
University of Tübingen
University of Tübingen
Local organizational units
Internal Medicine Department II
Department of Internal Medicine
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Funders
Brüssel, Belgium